Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) closed the day trading at $2.45 up 1.24% from the previous closing price of $2.42. In other words, the price has increased by $1.24 from its previous closing price. On the day, 2.75 million shares were traded. MRVI stock price reached its highest trading level at $2.535 during the session, while it also had its lowest trading level at $2.38.
Ratios:
For a better understanding of MRVI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.94 and its Current Ratio is at 10.74. In the meantime, Its Debt-to-Equity ratio is 1.63 whereas as Long-Term Debt/Eq ratio is at 1.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on February 26, 2025, Downgraded its rating to Neutral and sets its target price to $3 from $9 previously.
Goldman Downgraded its Neutral to Sell on December 05, 2024, while the target price for the stock was maintained at $4.25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 31 ’25 when ORESHACK KURT sold 25,000 shares for $5.03 per share. The transaction valued at 125,750 led to the insider holds 167,618 shares of the business.
ORESHACK KURT bought 25,000 shares of MRVI for $125,750 on Jan 31 ’25. On Nov 12 ’24, another insider, DeFord John A, who serves as the Director of the company, bought 17,500 shares for $5.75 each. As a result, the insider paid 100,625 and bolstered with 70,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 618693632 and an Enterprise Value of 650689600. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.23 while its Price-to-Book (P/B) ratio in mrq is 1.01. Its current Enterprise Value per Revenue stands at 2.35 whereas that against EBITDA is 628.079.
Stock Price History:
The Beta on a monthly basis for MRVI is 0.17, which has changed by -0.69221103 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is -43.39%, while the 200-Day Moving Average is calculated to be -63.96%.
Shares Statistics:
Over the past 3-months, MRVI traded about 2.79M shares per day on average, while over the past 10 days, MRVI traded about 3687320 shares per day. A total of 141.59M shares are outstanding, with a floating share count of 117.88M. Insiders hold about 16.89% of the company’s shares, while institutions hold 86.83% stake in the company. Shares short for MRVI as of 1740700800 were 8822415 with a Short Ratio of 3.16, compared to 1738281600 on 8540093. Therefore, it implies a Short% of Shares Outstanding of 8822415 and a Short% of Float of 7.4200004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
